Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  29 (2025)
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 9 , ISSUE 1 ( January, 2005 ) > List of Articles

ORIGINAL ARTICLE

Cerebral venous thrombosis: An experience with anticoagulation with low molecular weight heparin

Lalitha V. Pillai, Dhananjay P. Ambike, Satish Nirhale, S. M. K. Husainy, Satish Pataskar

Keywords : Heparin, cerebral venous sinus thrombosis, low molecular weight heparin, oral contraceptive, homocysteine

Citation Information : Pillai LV, Ambike DP, Nirhale S, Husainy SM, Pataskar S. Cerebral venous thrombosis: An experience with anticoagulation with low molecular weight heparin. Indian J Crit Care Med 2005; 9 (1):14-18.

DOI: 10.4103/0972-5229.16263

License: CC BY-ND 3.0

Published Online: 01-09-2009

Copyright Statement:  Copyright © 2005; The Author(s).


Abstract

Cerebral venous sinus thrombosis [CVST] is often an infrequent cause of neurological dysfunction resulting in admissions in Intensive care units [ICU]. Because of its myriad presentation it may be under diagnosed. Unfractionated Heparin [UFH] has been advocated in treatment but needs frequent monitoring. We studied the clinical profile of patients of cerebral venous sinus thrombosis, use of low molecular weight heparin [LMWH] with emphasis on safety in 64 patients of CVST.

PDF Share
  1. Bousser MG, Cerebral venous thrombosis; nothing, heparin, or local thrombolysis? Stroke 1999;30:481-3.
  2. Allroggen H, Abbott RJ. Cerebral venous sinus thrombosis Postgrad Med J 2000;76;12-5.
  3. Srinivasan K. Ischemic cerebrovasular disease in the young: Two common causes in India. Stroke 1984;15;733-5.
  4. Nagaraja D, Sarma GR. Treatment of cerebral sinus/venous thrombosis. Neurol India 2002;50;2:114-6.
  5. de Bruijn SF, Stam J. For the CVST Study Group. Randomized, placebo controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484-8.
  6. Deschiens M. Coagulation studies, factor V leiden, and anticadiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27;1724-30.
  7. Schaller B, Graf R. Cerebral Venous Infarction: The Pathophysiological Concept. Cerebrovasc Dis 2004;18:179-88.
  8. Bousser MG, Chiras J, Sauron B, et al. Cerebral venous thrombosis. A review of 38 cases. Stroke 1985;116:199-213.
  9. Halpern JP, Morris JG, Driscoll GL. Anticoagulants and cerebral venous thrombosis. Aust N Z J Med 1984;14:643-8.
  10. Nagaraja D, Taly AB, Haridas VT, et al. Heparin in hemorrhagic infarction in cerebral venous sinus thrombosis. J Asso phys India 1998;46:706-7.
  11. Diaz JM, Schiffman JS, Urban ES, Maccario M. Superior sagittal sinus thrombosis and pulmonary embolism: A syndrome rediscovered. Acta Neurol Scand 1992;86:390-6.
  12. Prakash C, Bansal BC. Cerebral venous thrombosis. J Indian Acad Clin Med 2000;5:55-61.
  13. Lensing AWA, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins: A meta-analysis. Arch Intern Med 1995;155;601-7.
  14. Hersh J, Siragusa S, Cosmic B, Ginsberg JS. Low molecular weight heparins [LMWH] in the treatment of patients with acute venous thromboembolism. Thromb Haemost 1995;74:360-3.
  15. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism: The Columbus investigators. N Engl J Med 1997;337:657-62.
  16. Fray JI, Muro GJ, Mcdougall CG, et al. Cerebral venous thrombosis - combined intrathrombus rtpa and intravenous heparin. Stroke 1999;30:489-94.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.